Salkever, David; Slade, Eric; Karakus, Mustafa - In: PharmacoEconomics 24 (2006) 2, pp. 123-139
Background: Rising public and private expenditure on antipsychotic medications is concentrated on the cost of second generation or `atypical' medications, which are more expensive than first generation medications and make up a rapidly growing share of all antipsychotic prescriptions. Previous...